On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

PYGL

glycogen phosphorylase L

The PYGL gene provides instructions for producing liver glycogen phosphorylase, an enzyme essential for breaking down glycogen into glucose in liver cells, playing a vital role in energy regulation. PYGL encodes liver glycogen phosphorylase, an enzyme found exclusively in the liver.

Chromosome 14q22.1 Autosomal recessive HGNC:9725 Tier C
PYGL 14q22.1 p arm q arm 14

PYGL is located on the long (q) arm of chromosome 14, at band 14q22.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 14 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The PYGL gene, also known as glycogen phosphorylase L, contains the genetic code for liver glycogen phosphorylase. This enzyme is specifically active within liver cells, where it plays a critical part in glucose metabolism. Its primary function is to break down glycogen, a complex sugar stored in the liver, into simpler sugars the body can use for energy.

Disruptions to this process due to genetic changes can lead to conditions that affect the body's energy supply, particularly a group of disorders known as glycogen storage diseases.

What the gene does

The PYGL gene directs the creation of liver glycogen phosphorylase, an enzyme belonging to a family of glycogen phosphorylases. Unlike related enzymes found in brain and muscle tissues, liver glycogen phosphorylase is found exclusively within liver cells. Its main role is to catalyse the conversion of glycogen, a stored form of glucose, into glucose-1-phosphate.

Through subsequent metabolic steps, glucose-1-phosphate is further processed into glucose. Glucose is a simple sugar that acts as the main energy source for most cells throughout the body. This enzyme, therefore, helps maintain consistent blood glucose levels and ensures a steady energy supply, particularly during fasting or between meals.

Video: Genetics 101

Chromosome location

The PYGL gene is located on chromosome 14, at the specific genomic position 14q22.1. This designation indicates that the gene resides on the long (q) arm of chromosome 14, within region 22, band 1.

Protein structure

The PYGL gene encodes a protein composed of 847 amino acids. The detailed domain architecture for this protein has not been extensively characterised through experimental studies.

Key variants

Variations within the PYGL gene can alter the functionality of the liver glycogen phosphorylase enzyme. Research indicates that most such variants lead to changes in single protein building blocks, known as amino acids, within the enzyme. These altered proteins may not efficiently break down glycogen, which can result in its accumulation within liver cells.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for PYGL.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1404-1G>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI
c.1475G>A
single nucleotide variant
p.Trp492Ter Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI
c.1620+1G>C
single nucleotide variant
- Pathogenic ★★☆☆ Glycogen storage disease, type VI
c.1726C>T
single nucleotide variant
p.Arg576Ter Pathogenic ★★☆☆ PYGL-related disorder
c.1729C>T
single nucleotide variant
p.Gln577Ter Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI
c.1964_1969+4delinsGAAAAA
Indel
- Pathogenic ★★☆☆ PYGL-related disorder
c.2071G>C
single nucleotide variant
p.Gly691Arg Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI
c.2426C>T
single nucleotide variant
p.Ser809Leu Pathogenic ★★☆☆ Glycogen storage disease, type VI
c.730C>T
single nucleotide variant
p.Leu244Phe Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI
c.772+1G>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type VI

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the PYGL gene are known to cause glycogen storage disease type VI (GSDVI). This autosomal recessive condition is characterised by the liver's impaired ability to properly break down glycogen, leading to its build-up. At least 17 different variants in the PYGL gene have been identified as causes of GSDVI. In the Old Order Mennonite population, a common variant has been identified, though full details of this common mutation were not provided in the source material.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic PYGL variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous PYGL carrier status across ancestry groups?

UK clinical status

The PYGL gene is recognised by the UK's NHS Genomic Medicine Service. It is categorised as 'green' on several NHS England National Genomic Test Directory panels, which signifies strong evidence supporting its association with disease. These panels include DDG2P, Glycogen storage disease (R274), Ketotic hypoglycaemia, Likely inborn error of metabolism (R98), and Undiagnosed metabolic disorders.

Frequently asked questions

What is the main function of the PYGL gene?

The PYGL gene provides instructions for making liver glycogen phosphorylase, an enzyme that breaks down glycogen stored in the liver into glucose. This glucose is then used by the body for energy.

What condition is associated with variants in the PYGL gene?

Variants in the PYGL gene are associated with glycogen storage disease type VI (GSDVI). This condition results from the liver's impaired ability to break down glycogen, leading to its accumulation.

Where is the PYGL gene located?

The PYGL gene is located on chromosome 14, specifically at position 14q22.1. This indicates its precise address on the long arm of chromosome 14.

References

  1. Beauchamp NJ, Taybert J, Champion MP. High frequency of missense mutations in glycogen storage disease type VI. Journal of inherited metabolic disease. 2007. PMID: 17705025
  2. Burwinkel B, Bakker HD, Herschkovitz E. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. American journal of human genetics. 1998. PMID: 9529348
  3. Chang S, Rosenberg MJ, Morton H. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Human molecular genetics. 1998. PMID: 9536091
  4. Adam MP, Bick S, Mirzaa GM. Glycogen Storage Disease Type VI. 1993. PMID: 20301760
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .